Why health tech’s best closers are handing prospects a tool, not a slide deck
You nailed the demo. They were engaged, asked great questions, said “this is exactly what we’ve been looking for.” Then Tuesday comes. Then Thursday. Two weeks pass and your follow-up emails are getting one-line replies.
What happened? The demo lived in the meeting. And the meeting is gone.
The 20+ Touchpoint Reality of HealthTech Sales
Healthtech deals don’t close in a single meeting. Research consistently shows that complex B2B purchases require 20 or more touchpoints before a buyer commits, and in healthcare, where sales cycles are long, stakeholder groups are large, and risk tolerance is low, that number often runs higher.
Most healthtech sellers understand this intellectually. But their sales motion doesn’t reflect it. They spend weeks preparing for the live demo, deliver it well, and then hand the baton to a follow-up email sequence that no one asked for. The demo gets one slot in a 20-touch journey. What’s filling the other 19?
One Demo Isn’t Enough
The live demo is a presentation to one person or one small group, at one moment in time. Even a great one has a shelf life measured in days, not weeks. By the time your champion is in their next internal meeting trying to build consensus around your solution, the energy from that call has already started to fade.
And your champion is working without you. They’re fielding questions from colleagues who weren’t on the demo, from finance who wants to understand ROI, from IT who wants to know about integrations. They’re doing that with whatever they retained from a screen share, plus maybe a deck you sent them afterward.
A slide deck isn’t a substitute for lived experience with a product. And in healthtech, when the buying committee is rarely one person, you can’t afford to have your entire case resting on one person’s memory of one call.
What lives with the prospect?
Here’s the question worth asking after every demo: what did you leave behind that will still be working for you seven days from now?
The answer for most healthtech sellers is: not much. Maybe a sales deck, maybe a one-pager. Which are inherently valuable, but they can’t tell the whole story on your behalf. And it doesn’t have to be that way.
The post-demo sandbox changes the dynamic. After your live demo, you give the prospect access to a limited, time-scoped version of your product to explore on their own. Seven days. One specific use case. Enough functionality to feel the value, not so much that they can extract your core IP without buying.
That last point matters, especially for data-driven tools. You’re not handing over the full dataset or unlocking every feature. You’re giving them a window, wide enough to get meaningful hands-on experience, narrow enough that they hit a ceiling. That ceiling is intentional. It’s the moment they feel the gap between what they have access to and what they’d have if they bought. You’re not just demonstrating value. You’re engineering the realization that they need the full product.
Every time they open the sandbox, that’s a touchpoint. Every time they share it with a colleague, that’s a touchpoint. Every time they bump against a limitation and think “I wish I had the full version,” that’s a touchpoint. All of it happening without a single additional call from your team.
The Champion Effect
The downstream impact on your internal champion is where this strategy really compounds.
Right now, your champion is walking into internal meetings with a recording no one will watch and a deck that looks very similar to every other vendor deck. With a sandbox, they’re walking in with a live tool. They can demonstrate it themselves and show a skeptical colleague exactly what it does for their specific workflow. They stop being a messenger for your pitch and start being an advocate with firsthand experience.
That’s your sales motion continuing inside the account without you in the room.
The sellers winning complex health tech deals aren’t the ones with the best demos. They’re the ones who’ve figured out how to stay present in the evaluation process after the demo ends, how to keep generating touches, building internal momentum, and making their product feel inevitable before the contract ever hits legal.
One great demo is a moment. A demonstration strategy is a pipeline strategy.
After your next demo, ask yourself: what am I leaving behind?
